1. Esposito G, Dottori L, Pivetta G, Ligato I, Dilaghi E, Lahner E. Pernicious Anemia: The Hematological Presentation of a Multifaceted Disorder Caused by Cobalamin Deficiency. Nutrients 2022;14(8):1672. https://doi.org/10.3390/nu14081672

2. Laisk T, Lepamets M, Koel M, Abner E, Metspalu A, Nelis M, et al. Genome-wide association study identifies five risk loci for pernicious anemia. Nat Commun 2021;12(1):3761. https://doi.org/10.1038/s41467-021-24051-6

3. Htut TW, Thein KZ, Oo TH. Pernicious anemia: Pathophysiology and diagnostic difficulties. J Evid Based Med 2021;14(2):161-9. https://doi.org/10.1111/jebm.12435

4. Green R. Vitamin B 12 deficiency from the perspective of a practicing hematologist. Blood 2017;129(19):2603-11. https://doi.org/10.1182/blood-2016-10-569186

5. Devalia V, Hamilton MS, Molloy AM. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol 2014;166(4):496-513. https://doi.org/10.1111/bjh.12959

6. Shah SC, Piazuelo MB, Kuipers EJ, Li D. AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review. Gastroenterology 2021;161(4):1325-32.e7. https://doi.org/10.1053/j.gastro.2021.06.078

7. Fenaux P, Platzbecker U, Ades L. How we manage adults with myelodysplastic syndrome. Br J Haematol 2020;189(6):1016-27. https://doi.org/10.1111/bjh.16206

8. Garcia-Manero G, Chien KS, Montalban-Bravo G. Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management. Am J Hematol 2020;95(11):1399-420. https://doi.org/10.1002/ajh.25950

9. Lee P, Yim R, Yung Y, Chu HT, Yip PK, Gill H. Molecular targeted therapy and immunotherapy for myelodysplastic syndrome. Int J Mol Sci 2021;22(19):10232. https://doi.org/10.3390/ijms221910232